233 related articles for article (PubMed ID: 35222288)
1. Limited Role of Hair Cortisol and Cortisone Measurement for Detecting Cortisol Autonomy in Patients With Adrenal Incidentalomas.
Puglisi S; Leporati M; Amante E; Parisi A; Pia AR; Berchialla P; Terzolo M; Vincenti M; Reimondo G
Front Endocrinol (Lausanne); 2022; 13():833514. PubMed ID: 35222288
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
[TBL] [Abstract][Full Text] [Related]
3. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
[TBL] [Abstract][Full Text] [Related]
4. Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing's syndrome.
Brossaud J; Charret L; De Angeli D; Haissaguerre M; Ferriere A; Puerto M; Gatta-Cherifi B; Corcuff JB; Tabarin A
Eur J Endocrinol; 2021 Mar; 184(3):445-454. PubMed ID: 33449913
[TBL] [Abstract][Full Text] [Related]
5. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
Ceccato F; Barbot M; Albiger N; Antonelli G; Zilio M; Todeschini M; Regazzo D; Plebani M; Lacognata C; Iacobone M; Mantero F; Boscaro M; Scaroni C
Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
[TBL] [Abstract][Full Text] [Related]
6. Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.
Debono M; Harrison RF; Chadarevian R; Gueroult C; Abitbol JL; Newell-Price J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3461-3469. PubMed ID: 28911138
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Salivary Cortisone in the Overnight Dexamethasone Suppression Test in Adrenal Incidentalomas.
Issa BG; Hanna FWF; Fryer AA; Ensah G; Ebere I; Marshall D; Keevil B
J Clin Endocrinol Metab; 2023 Sep; 108(10):e937-e943. PubMed ID: 37155577
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism.
Berndt V; Dahlqvist P; de Verdier J; Ryberg H; Ragnarsson O
Front Endocrinol (Lausanne); 2022; 13():1028804. PubMed ID: 36506050
[TBL] [Abstract][Full Text] [Related]
9. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
[TBL] [Abstract][Full Text] [Related]
10. The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.
Morelli V; Polledri E; Mercadante R; Zhukouskaya V; Palmieri S; Beck-Peccoz P; Spada A; Fustinoni S; Chiodini I
Endocrine; 2016 Sep; 53(3):809-15. PubMed ID: 26438395
[TBL] [Abstract][Full Text] [Related]
11. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
[TBL] [Abstract][Full Text] [Related]
12. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
[TBL] [Abstract][Full Text] [Related]
14. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
[TBL] [Abstract][Full Text] [Related]
15. Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.
Vogg N; Kurlbaum M; Deutschbein T; Gräsl B; Fassnacht M; Kroiss M
Clin Chem; 2021 Jul; 67(7):998-1007. PubMed ID: 33997885
[TBL] [Abstract][Full Text] [Related]
16. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
Rodrigues MO; Moraes AB; de Paula MP; Pereira VA; Leão ATT; Vieira Neto L
J Endocrinol Invest; 2021 Nov; 44(11):2455-2463. PubMed ID: 33788166
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
[TBL] [Abstract][Full Text] [Related]
18. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
[TBL] [Abstract][Full Text] [Related]
19. Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome.
Bäcklund N; Brattsand G; Israelsson M; Ragnarsson O; Burman P; Edén Engström B; Høybye C; Berinder K; Wahlberg J; Olsson T; Dahlqvist P
Eur J Endocrinol; 2020 Jun; 182(6):569-582. PubMed ID: 32213657
[TBL] [Abstract][Full Text] [Related]
20. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
